Pay in 4 interest-free payments of $5.43 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Lefkofsky told Forbes in 2019 he started the company after his wife was diagnosed with breast cancer, leaving him just perplexed at how little data had permeated her care. By 2019, Tempus had raised $520 million, including $100 million from Lefkofsky, and he told Forbes he hoped Tempus would be his legacy project. Lefkofsky took Tempus public in 2024, at which time his stake was worth $2.2 billion
S., Rocha, J
The glucose-dependent insulinotropic polypeptide (GIP) regulates body weight and food intake via CNSGIPR signaling
You will be able to find information on these medications in the relevant section below
US$ 25.67
US$ 28.23
US$ 28.37
US$ 22.45
US$ 22.63
